Stockreport

Zealand Pharma and OTR to develop metabolic disease therapeutics [Yahoo! Finance]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF The multi-programme partnership leverages Zealand Pharma's experience in obesity and metabolic health alongside OTR Therapeutics' research and development (R&D) platfor [Read more]